A Multicenter Prospective Post-registration Study of Empegfilgrastim to Evaluate Safety and Efficacy in Special Cancer Populations
Clinical trial NCT04905329 · UNKNOWN
Trial details
- NCT number
- NCT04905329
- Sponsor
- Moscow Clinical Scientific Center
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2020-04-28
- Primary completion
- 2022-12-31
- Enrollment
- 285
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.